Figure 1From: Tranexamic acid attenuates inflammatory response in cardiopulmonary bypass surgery through blockade of fibrinolysis: a case control study followed by a randomized double-blind controlled trialLevels of interleukin-6 (IL-6) at 4 hours between inflammatory response (IR) patients and non-IR patients. ICU, intensive care unit.Back to article page